Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Hepatitis C treatment
Taribavirin offers a safe, effective alternative for chronic hepatitis C

Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response in patients with chronic hepatitis C.

Published
22 September 2010
From
Eurekalert Medicine & Health
Hepatitis C treatment
Partial hep C treatment response offers health benefits

Even a partial response to hepatitis C virus (HCV) therapy confers significant health benefits to people coinfected with both HIV and HCV, though not as much as a full response. These data were presented September 14 at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston.

Published
20 September 2010
From
AIDSMeds.com
Hepatitis A
HIV-Positive Men Need a Booster Dose of the Hep A Vaccine

HIV-positive men who have sex with men (MSM)  required an extra booster dose to have an equivalent response to the vaccine as HIV-negative men, findings presented at the 50th ICAAC show.

Published
15 September 2010
From
AIDSMeds.com
Hepatitis B
Abbott receives FDA approval for first automated molecular test for assessing hepatitis B treatment

Abbott announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood.

Published
01 September 2010
From
Abbott
New and experimental hepatitis C treatment
Vertex releases results of phase III study of telaprevir in hepatitis C

Vertex Pharmaceuticals today announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 weeks in people whose hepatitis C virus (HCV) was undetectable at weeks 4 and 12 of treatment (extended rapid viral response or eRVR).

Published
10 August 2010
From
Business Wire
Tattooing linked to higher risk of hepatitis C: UBC study

(University of British Columbia) Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a University of British Columbia study.

Published
06 August 2010
From
Eurekalert
Hepatitis C treatment
Depression overlooked in patients with hepatitis C; compromising HCV therapy

Researchers from Denmark, Sweden, Norway and Finland (the NORDynamIC project group) have observed that depressive symptoms in patients with hepatitis C virus (HCV) infection are commonly overlooked in routine clinical interviews, and that treatment-induced depression compromises the outcome of HCV therapy.

Published
20 July 2010
From
Eurekalert Medicine & Health
Limits to methadone prescription proposed by UK drugs agency

Strict limits on how long drug addicts are allowed to stay on heroin substitute methadone have been proposed by the government body responsible for treatment strategy, in what will be seen as a watershed in UK drugs policy.

Published
19 July 2010
From
The Guardian
Hepatitis C transmission and prevention
Hepatitis C carrier charged with spitting on police

Published
15 July 2010
From
Journal & Chronicle, Lafayette
Hepatitis C treatment
Medivir reports 24-week interim phase 2b results of TMC-435 in treatment-naive patients with HCV genotype 1

Published
12 July 2010
From
The Medical News
← Prev1...151152153154155Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.